During the past decade, Spectrum Neuroscience and Treatment Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Spectrum Neuroscience and Treatment Institute" are "Autistic Disorder" (1 trials), "Obsessive-Compulsive Disorder" (1 trials) and "Obsessive-compulsive Disorders and Symptoms" (1 trials). Many other conditions were trialed in "Spectrum Neuroscience and Treatment Institute" in a lesser frequency.

Most popular intervention types in "Spectrum Neuroscience and Treatment Institute" are "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "BIXINK OC Free" (1 trials), "Medical Food : Vayarin_005" (1 trials) and "Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Spectrum Neuroscience and Treatment Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Spectrum Neuroscience and Treatment Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Spectrum Neuroscience and Treatment Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Spectrum Neuroscience and Treatment Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".